Adacel

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

Pertussis fimbriae 2 + 3; Pertussis filamentous haemagglutinin; Tetanus toxoid; Diphtheria toxoid; Pertactin; Pertussis toxoid

Tillgänglig från:

Sanofi-Aventis Australia Pty Ltd

Klass:

Medicine Registered

Bipacksedel

ADACEL
®

_Pertussis Vaccine - Acellular Combined with Diphtheria and Tetanus
Toxoids (Adsorbed)_
CONSUMER MEDICINE INFORMATION

WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about ADACEL
®
.
It does not contain all the available
information.
It does not take the place of talking to
your doctor or pharmacist.
All medicines, including vaccines,
have risks and benefits. Your doctor
has weighed the risks of you having
ADACEL
®
 against the benefits they
expect it will have.
IF YOU HAVE ANY CONCERNS ABOUT THIS
VACCINE, ASK YOUR DOCTOR, NURSE OR
PHARMACIST.
KEEP THIS LEAFLET. YOU MAY NEED TO
READ IT AGAIN.
WHAT ADACEL
®
 IS
USED FOR
ADACEL
®
 is a vaccine used to help
prevent whooping cough (pertussis),
tetanus and diphtheria.
This vaccine is for use as a booster in
persons from the age of 10 years who
have previously received childhood
immunisation.
ADACEL
®
 is not intended for
childhood immunisation.
The use of ADACEL
®
 should be
determined on the basis of official
recommendations and by your
doctor.
Whooping cough, tetanus and
diphtheria cause significant sickness
and sometimes death in unvaccinated
infants, children, and adults.
_HOW IT WORKS_
ADACEL
®
 works by causing the
body to produce its own protection
against whooping cough, tetanus, and
diphtheria. It does this by making
substances called antibodies in the
blood, which fight the bacteria and
toxins that cause these diseases. If a
vaccinated person comes into contact
with these bacteria and toxins, the
body is usually ready to destroy
them.
It usually takes several weeks after
vaccination to develop protection
against these diseases.
A course of whooping cough, tetanus
and diphtheria vaccine is usually
given during early childhood at 2, 4
and 6 months of age, followed by a
booster at 4 years of age. In case of
whooping cough, tetanus and
diphtheria, a second booster is
required at the age of 15-17 years.
Most people will produce enough
antibodies against these diseases.
However, as with all vaccines, 100%
p

Produktens egenskaper

SANOFI PASTEUR 
ADACEL PERTUSSIS VACCINE – ACELLULAR COMBINED WITH DIPHTHERIA AND TETANUS TOXOID
(ADSORBED) 

PAGE 1 OF 9 
AUSTRALIAN 
PRODUCT INFORMATION 

NAME OF THE MEDICINE 
ADACEL


Pertussis Vaccine-Acellular Combined with Diphtheria and Tetanus
Toxoids (Adsorbed)  
DESCRIPTION  
ADACEL is a sterile, uniform, cloudy, white
suspension for injection. 
Each 0.5 mL dose of ADACEL contains: 
2.5 

g                            pertussis toxoid 
5 

g                               pertussis
filamentous haemagglutinin 
5 

g                               pertussis
fimbriae types 2 and 3  
3 

g                               pertussis pertactin 

 2 IU (2 LfU)              diphtheria toxoid 

 20 IU (5 LfU)*          tetanus toxoid 
1.5 mg                           aluminium phosphate
(equivalent to 0.33mg aluminium) 
0.6% v/v                        phenoxyethanol 

 0.005mg                     formaldehyde 

 0.02mg                       glutaraldehyde 
water for injections to 0.5mL 
*The  formulated  content  of  5LfU  per  0.5mL  dose  of  tetanus  toxoid  is  the  same  as  the  related 
product Tripacel
®
. 
The  vaccine  is  prepared  from:  adsorbed  purified  and  formaldehyde  detoxified  diphtheria  and 
tetanus toxins; adsorbed purified and glutaraldehyde detoxified pertussis toxin (pertussis toxoid or 
PT);  adsorbed  purified  and  formaldehyde  treated  filamentous  haemagglutinin  (FHA);  adsorbed 
purified pertactin (PRN) and fimbriae types 2 and 3 (FIM). 
ADACEL  is  an  adult/adolescent  formulation  diphtheria-tetanus-acellular  pertussis  (dTpa) 
combination  vaccine  with  reduced  content  of  pertussis  toxoid,  filamentous  haema